Clinical trial
An Open-Label, Pilot Study of Daratumumab SC in Patients With Mild to Moderate Alzheimer's Disease
NCT04070378 is registered in ClinicalTrials.gov with Marc L Gordon, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Pilot Study of Daratumumab SC in Patients With Mild to Moderate Alzheimer's Disease
- Lead sponsor
- Marc L Gordon, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 6, 2019
- Completion date
- August 15, 2023
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.